DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Serious Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Events (698)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) serious events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 698   Next >>

Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, unk
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2 df, unk
    Start date: 2011-11-21

Norvir
    Dosage: 100 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Isentress
    Dosage: 800 mg, qd
    Start date: 2011-11-21



Possible Reyataz side effects in 46 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27

Patient: 46 year old male

Reactions: Cholelithiasis, Pancreatitis Necrotising

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Norvir; Truvada; Crestor



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 36 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Epivir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 52 year old female

Reported by a consumer/non-health professional from France on 2012-08-27

Patient: 52 year old female

Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Irbesartan; Effexor; Truvada; Sulfamethoxazole and Trimethoprim; Nexium; Vitamin A; Ciprofloxacin Hydrochloride; Norvir; Propranolol



Possible Reyataz side effects in 31 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 31 year old female

Reactions: Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: 100 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Truvada
    Dosage: 1 tab/caps daily taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Reyataz
    Dosage: 300 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17



Possible Reyataz side effects in 52 year old female

Reported by a physician from France on 2012-08-27

Patient: 52 year old female

Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Propranolol; Vitamin A; Truvada; Irbesartan; Ciprofloxacin Hydrochloride; Nexium; Effexor; Norvir



Possible Reyataz side effects in 35 year old male

Reported by a physician from Japan on 2012-08-24

Patient: 35 year old male

Reactions: Renal Impairment, Cytomegalovirus Chorioretinitis, Hypoaesthesia, Mycobacterium Avium Complex Infection, Hyperuricaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Valganciclovir
    Administration route: Oral
    Indication: Cytomegalovirus Chorioretinitis
    Start date: 2010-05-19
    End date: 2010-06-30

Valganciclovir
    Administration route: Oral
    Start date: 2010-07-01
    End date: 2011-01-20

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-10-22
    End date: 2011-03-31

Mycobutin
    Administration route: Oral
    Indication: Mycobacterium Avium Complex Infection
    Start date: 2009-11-20
    End date: 2009-12-11

Epzicom
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-12-11
    End date: 2010-09-20

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-10-22
    End date: 2009-12-02

Prezista
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-12-03
    End date: 2011-03-31

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-10-22
    End date: 2009-12-02

Valganciclovir
    Administration route: Oral
    Indication: Cytomegalovirus Infection
    Start date: 2010-01-06
    End date: 2010-06-30

Valganciclovir
    Administration route: Oral
    Indication: Mycobacterium Avium Complex Infection
    Start date: 2010-02-16
    End date: 2010-03-24

Other drugs received by patient: Isentress; Pentamidine Isethionate; Intelence; Semen Coicis; Clindamycin Phosphate; Chlorhexidine Gluconate



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male

Reactions: Congenital Bladder Anomaly, Urethral Valves, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder

Drug(s) suspected as cause:
Lisinopril
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Atorvastatin
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: female

Reactions: Pulmonary Hypertension, Syndactyly, Congenital Hand Malformation, Patent Ductus Arteriosus, Ventricular Septal Defect, Single Umbilical Artery

Drug(s) suspected as cause:
Emtricitabine / Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Indication: HIV Infection
    Start date: 2012-01-25

Reyataz
    Dosage: 300 mg, qd
    Indication: HIV Infection
    Start date: 2012-01-25

Zidovudine
    Dosage: 2 mg/kg, q1hr
    Indication: Antiretroviral Therapy
    Start date: 2012-05-22
    End date: 2012-05-22

Zidovudine
    Dosage: 1 mg/kg, q1hr
    Start date: 2012-05-22
    End date: 2012-05-22

Ritonavir
    Dosage: 100 mg, qd
    Indication: HIV Infection
    Start date: 2012-01-25



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: 36 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy

Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Norvir
    Dosage: daily
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 66 year old male

Reported by a physician from Japan on 2012-08-24

Patient: 66 year old male

Reactions: Glomerulonephritis Chronic

Drug(s) suspected as cause:
Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-15

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-15

Epzicom
    Dosage: 1df: 1tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-06-27

Other drugs received by patient: Depakene



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-23

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21



Possible Reyataz side effects in

Reported by a physician from United States on 2012-08-23

Patient: , weighing 1.9 kg (4.2 pounds)

Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation

Drug(s) suspected as cause:
Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Raltegravir
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in female

Reported by a physician from Japan on 2012-08-21

Patient: female

Reactions: Renal Impairment, Diarrhoea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-06
    End date: 2011-05-30

Norvir
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-04-27
    End date: 2011-05-30

Tenofovir Disoproxil Fumarate
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-06
    End date: 2011-05-30

Other drugs received by patient: Candesartan Cilexetil; Epivir; Isentress; Candesartan Cilexetil; Zyrtec; Epzicom



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: female

Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Truvada
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Reyataz
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-21

Patient: male

Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: male

Reactions: Urethral Valves, Congenital Hydronephrosis

Drug(s) suspected as cause:
Atorvastatin
    Indication: Blood Triglycerides Increased

Lisinopril
    Indication: Hypertension

Reyataz
    Dosage: 300 mg, qd
    Indication: HIV Infection

Emtricitabine / Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Indication: HIV Infection

Zidovudine
    Dosage: unk
    Indication: HIV Infection
    Start date: 2011-10-13
    End date: 2011-10-13

Zidovudine
    Dosage: unk

Ritonavir
    Dosage: 100 mg, qd
    Indication: HIV Infection

Atorvastatin
    Indication: LOW Density Lipoprotein Increased



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: female

Reactions: Pulmonary Hypertension, Syndactyly, Congenital Hand Malformation, Patent Ductus Arteriosus, Ventricular Septal Defect, Single Umbilical Artery

Drug(s) suspected as cause:
Reyataz
    Dosage: 300 mg, qd
    Indication: HIV Infection
    Start date: 2012-01-25

Emtricitabine / Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Indication: HIV Infection
    Start date: 2012-01-25

Zidovudine
    Dosage: 2 mg/kg, q1hr
    Indication: Antiretroviral Therapy
    Start date: 2012-05-22
    End date: 2012-05-22

Zidovudine
    Dosage: 1 mg/kg, q1hr
    Start date: 2012-05-22
    End date: 2012-05-22

Ritonavir
    Dosage: 100 mg, qd
    Indication: HIV Infection
    Start date: 2012-01-25



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient:

Reactions: Vertical Talus

Drug(s) suspected as cause:
Lamivudine + Zidovudine
    Dosage: 2 df, qd
    Indication: HIV Infection
    Start date: 2011-11-21

Emtricitabine / Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Ritonavir
    Dosage: 100 mg, qd
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300 mg, qd
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800 mg, qd
    Indication: HIV Infection
    Start date: 2011-11-21



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: male

Reactions: Bladder Dilatation, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male, weighing 3.7 kg (8.2 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 3.7 kg (8.1 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    End date: 2011-11-10

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-10
    End date: 2012-06-07

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy

Other drugs received by patient: Retrovir; Fluconazole; Terazol Cream; Retrovir; Unspecified Medication



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Cytogenetic Abnormality, Brain Malformation, Spina Bifida, Abortion Induced, Vertical Talus

Adverse event resulted in: death

Drug(s) suspected as cause:
Isentress
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: female, weighing 3.7 kg (8.1 pounds)

Reactions: Neurofibromatosis, Foetal Exposure During Pregnancy, Cafe AU Lait Spots

Drug(s) suspected as cause:
Truvada

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: male

Reactions: Bladder Dilatation, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-16

Patient: female

Reactions: Oligohydramnios, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Norvir
    Dosage: 1 film coated tablet daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-24



Possible Reyataz side effects in male

Reported by a consumer/non-health professional from France on 2012-08-16

Patient: male

Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Start date: 2012-01-24

Norvir
    Dosage: 1 film coated tablet daily
    Start date: 2012-01-24

Truvada
    Start date: 2011-01-24



Possible Reyataz side effects in 35 year old male

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 35 year old male

Reactions: Road Traffic Accident

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient: Carvedilol; Olanzapine; Exforge; Metformin Hydrochloride; Ritonavir; Ibuprofen; Truvada



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014